OPHLY.US Ono Pharmaceutical Co Ltd

Healthcare Pharmaceuticals USA Stocks
5.16 USD
Close of Nov 15, 2026
4.01 5.43
Market cap
USD 7.28B
P/E
15.2x
P/B
1.33x
ROE
10.3%
Dividend yield
3.26%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is OPHLY.US undervalued?

Graham number
Price5.16
Graham value5.45
Discount5.4%

OPHLY.US trades 5.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ono Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Ono Pharmaceutical Co Ltd yet.

Ono Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ono Pharmaceutical Co Ltd

Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo intravenous infusion and Kyprolis intravenous injection for malignant tumors; Emend capsule intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; Mektovi, Velexbru, and Braftovi capsules for malignant tumors; and ADLUMIZ tablets for cancer cachexia. The company also p…

Full company profile